Summary of Significant Accounting Policies (Effect of Revision on Affected Line Items Within Consolidated Statements of Cash Flows) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Mar. 31, 2025	Mar. 31, 2024
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	$ 10,274	$ 10,498	$ 30,267	$ 29,879
Changes in assets and liabilities:
Cloud computing implementation assets			(21,959)	(19,262)
Accounts payable			(9,978)	12,632
Net cash provided by operating activities-continuing operations			273,813	227,111
Net cash provided by operating activities			278,207	235,507
Investing activities:
Capital expenditures			(31,337)	(32,316)
Net cash used in investing activities-continuing operations				(32,188)
Net cash used in investing activities			(30,265)	(32,188)
Non-cash investing and financing activities:
Accrued capital expenditures			$ 12,410	6,217
As Reported
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation				32,106
Changes in assets and liabilities:
Accounts payable				10,841
Net cash provided by operating activities-continuing operations				246,809
Net cash provided by operating activities				255,205
Investing activities:
Capital expenditures				(52,014)
Net cash used in investing activities-continuing operations				(51,886)
Net cash used in investing activities				(51,886)
Non-cash investing and financing activities:
Accrued capital expenditures				11,086
Adjustment
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation				(2,227)
Changes in assets and liabilities:
Cloud computing implementation assets				(19,262)
Accounts payable				1,791
Net cash provided by operating activities-continuing operations				(19,698)
Net cash provided by operating activities				(19,698)
Investing activities:
Capital expenditures				19,698
Net cash used in investing activities-continuing operations				19,698
Net cash used in investing activities				19,698
Non-cash investing and financing activities:
Accrued capital expenditures				$ (4,869)